FI946189A0 - 17-alkyl ketone steroids useful as 5-alpha-reductase inhibitors - Google Patents
17-alkyl ketone steroids useful as 5-alpha-reductase inhibitorsInfo
- Publication number
- FI946189A0 FI946189A0 FI946189A FI946189A FI946189A0 FI 946189 A0 FI946189 A0 FI 946189A0 FI 946189 A FI946189 A FI 946189A FI 946189 A FI946189 A FI 946189A FI 946189 A0 FI946189 A0 FI 946189A0
- Authority
- FI
- Finland
- Prior art keywords
- alpha
- reductase inhibitors
- alkyl ketone
- steroids useful
- ketone steroids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929213835A GB9213835D0 (en) | 1992-06-30 | 1992-06-30 | Compounds |
PCT/US1993/006238 WO1994000125A1 (en) | 1992-06-30 | 1993-06-30 | 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS |
Publications (2)
Publication Number | Publication Date |
---|---|
FI946189A0 true FI946189A0 (en) | 1994-12-30 |
FI946189A FI946189A (en) | 1994-12-30 |
Family
ID=10717920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI946189A FI946189A (en) | 1992-06-30 | 1994-12-30 | 17-Alkyl ketone steroids useful as 5-alpha reductase inhibitors |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0651643A4 (en) |
JP (1) | JPH08500821A (en) |
KR (1) | KR950702118A (en) |
CN (1) | CN1095382A (en) |
AP (1) | AP412A (en) |
AU (1) | AU4545993A (en) |
BG (1) | BG99313A (en) |
BR (1) | BR9306748A (en) |
CA (1) | CA2138956A1 (en) |
CZ (1) | CZ334694A3 (en) |
FI (1) | FI946189A (en) |
GB (1) | GB9213835D0 (en) |
HU (1) | HUT69409A (en) |
IL (1) | IL106158A0 (en) |
MA (1) | MA22927A1 (en) |
MX (1) | MX9303970A (en) |
NO (1) | NO945074L (en) |
OA (1) | OA10122A (en) |
RU (1) | RU94046378A (en) |
SI (1) | SI9300350A (en) |
SK (1) | SK159994A3 (en) |
WO (1) | WO1994000125A1 (en) |
ZA (1) | ZA934645B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925774A (en) * | 1991-01-07 | 1999-07-20 | Pherin Corporation | Estrenes for inducing hypothalamic effects |
EP0646007B1 (en) * | 1992-05-20 | 1997-08-13 | Merck & Co. Inc. | NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONES AS 5$g(a)-REDUCTASE INHIBITORS |
US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
GB201102913D0 (en) | 2011-02-18 | 2011-04-06 | Univ Birmingham | Novel therapeutic |
JP2015129095A (en) | 2013-12-19 | 2015-07-16 | ロレアル | composition |
BR112020016269A2 (en) * | 2018-02-11 | 2020-12-15 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | STEROID DERIVED REGULATORS, METHOD TO PREPARE THEM AND THEIR USES |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954446A (en) * | 1988-05-25 | 1990-09-04 | Smithkline Beecham Corporation | Aromatic steroid 5-α-reductase inhibitors |
-
1992
- 1992-06-30 GB GB929213835A patent/GB9213835D0/en active Pending
-
1993
- 1993-06-26 ZA ZA934645A patent/ZA934645B/en unknown
- 1993-06-28 MA MA23217A patent/MA22927A1/en unknown
- 1993-06-28 IL IL106158A patent/IL106158A0/en unknown
- 1993-06-30 BR BR9306748A patent/BR9306748A/en not_active Application Discontinuation
- 1993-06-30 RU RU94046378/04A patent/RU94046378A/en unknown
- 1993-06-30 CN CN93109540A patent/CN1095382A/en active Pending
- 1993-06-30 AU AU45459/93A patent/AU4545993A/en not_active Abandoned
- 1993-06-30 MX MX9303970A patent/MX9303970A/en unknown
- 1993-06-30 SI SI9300350A patent/SI9300350A/en unknown
- 1993-06-30 CZ CZ943346A patent/CZ334694A3/en unknown
- 1993-06-30 WO PCT/US1993/006238 patent/WO1994000125A1/en not_active Application Discontinuation
- 1993-06-30 EP EP93915499A patent/EP0651643A4/en not_active Withdrawn
- 1993-06-30 JP JP6502660A patent/JPH08500821A/en active Pending
- 1993-06-30 SK SK1599-94A patent/SK159994A3/en unknown
- 1993-06-30 HU HU9403833A patent/HUT69409A/en unknown
- 1993-06-30 CA CA002138956A patent/CA2138956A1/en not_active Abandoned
- 1993-06-30 AP APAP/P/1993/000542A patent/AP412A/en active
-
1994
- 1994-12-29 BG BG99313A patent/BG99313A/en unknown
- 1994-12-29 NO NO945074A patent/NO945074L/en unknown
- 1994-12-29 KR KR1019940704802A patent/KR950702118A/en not_active Application Discontinuation
- 1994-12-29 OA OA60599A patent/OA10122A/en unknown
- 1994-12-30 FI FI946189A patent/FI946189A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH08500821A (en) | 1996-01-30 |
NO945074D0 (en) | 1994-12-29 |
SK159994A3 (en) | 1996-01-10 |
BR9306748A (en) | 1998-12-08 |
MX9303970A (en) | 1994-04-29 |
WO1994000125A1 (en) | 1994-01-06 |
ZA934645B (en) | 1994-01-25 |
AP9300542A0 (en) | 1993-07-31 |
BG99313A (en) | 1995-09-29 |
EP0651643A4 (en) | 1995-10-04 |
RU94046378A (en) | 1996-10-10 |
IL106158A0 (en) | 1993-10-20 |
AU4545993A (en) | 1994-01-24 |
CA2138956A1 (en) | 1994-01-06 |
CN1095382A (en) | 1994-11-23 |
CZ334694A3 (en) | 1995-10-18 |
FI946189A (en) | 1994-12-30 |
OA10122A (en) | 1996-12-18 |
HUT69409A (en) | 1995-09-28 |
AP412A (en) | 1995-09-29 |
MA22927A1 (en) | 1994-04-01 |
NO945074L (en) | 1995-02-16 |
KR950702118A (en) | 1995-06-19 |
GB9213835D0 (en) | 1992-08-12 |
EP0651643A1 (en) | 1995-05-10 |
SI9300350A (en) | 1993-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0802184T3 (en) | N-Benzyl-2-phenylindoles as estrogenic agents | |
NO940305D0 (en) | Kinazoline derivatives as acetylcholine esterase inhibitors | |
AU531537B2 (en) | Method for sanitizing toilets | |
NO980467L (en) | 4-mercaptopyrrolidine derivatives as farnesyl transerase inhibitors | |
IS7292A (en) | Substituted benzenesulfonamide derivatives as progenitors for COX-2 inhibitors | |
DK0818448T3 (en) | Cycloalkanopyridines as CETP inhibitors | |
NO961432D0 (en) | Benzophiophenes and related compounds as estrogen agonists | |
NO881857L (en) | STEROID 5-ALFA REDUCTASE INHIBITORS. | |
NO992725D0 (en) | 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors | |
NO992821D0 (en) | Ketobenzamides as Calpain Inhibitors | |
FI931069A0 (en) | KOLLOIDALT ROSTAT KAFFE SOM AROMATISERINGSPRODUKT | |
DK0606248T3 (en) | Heteroberlamines as novel acetylcholinesterase inhibitors | |
FI891438A0 (en) | FOERFARANDE FOER FRAMSTAELLNING AV PHARMACEUTISKA SAMMANSAETTNINGAR SOM INVERKAR I SYNNERHET PAO DET KARDIOVASKULAERA SYSTEMET. | |
DE69526475D1 (en) | 5-alpha-reductase inhibitors | |
MX9200731A (en) | HYDRAZONE COMPOUNDS, PROCEDURES FOR ITS HYDRAZONE COMPOUNDS, PROCEDURES FOR ITS PREPARATION, INTERMEDIATE COMPOUNDS USEFUL FOR ITS OPERATION, INTERMEDIATE COMPOUNDS USEFUL FOR ITS OBTAINMENT AND PESTICIDED COMPOSITIONS THAT CONTAIN MESSAGE AND MISCELLANEOUS COMPOSITIONS CONTAINING BTENTIONAL COMPOSITIONS. THE SAME. | |
FI946189A0 (en) | 17-alkyl ketone steroids useful as 5-alpha-reductase inhibitors | |
NO922167D0 (en) | AMINODECTS AS CORROSION INHIBITORS | |
EP0650358A4 (en) | 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors. | |
IS2271B (en) | Anti-inflammatory agent for topical use | |
NO965165D0 (en) | Use of 8,9-dehydroestrone as an antioxidant | |
NO933622D0 (en) | BENZENDIMETANOL SUITABLE FOR MICRONIZATION | |
FI930385A0 (en) | LATEXFAERG SOM TAOL LOESNINGSMEDEL | |
MX9203759A (en) | STEROIDAL 5-ALPHA-REDUCTASE INHIBITORS. | |
FI944023A0 (en) | Foerfarande Foer identifiering av avelselser i en yta som granskas | |
ES1029636Y (en) | INFORMATIVE PANEL FOR INVIDENTS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |